Physician profile
Panagiotis Iakovidis
NPI 1619974185
$1,620.87
in general payments reported to CMS, 2019-2025
25 companies · $585 in 2025
The $585 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $352 · 2020: $27.47 · 2021: $157 · 2022: $87.11 · 2023: $147 · 2024: $265 · 2025: $585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $997.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $997.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $332.01 | 2024-2025 | Nuzyra |
| Smith+Nephew, INC. | $197.05 | 2022-2025 | Grafix Pl, Collagenase Santyl, Renasys Touch |
| Bard Peripheral Vascular, INC. | $144.32 | 2019 | |
| Janssen Pharmaceuticals, INC | $133.74 | 2019-2023 | Xarelto |
| Medtronic Vascular, INC. | $89.53 | 2019 | |
| Lexington Medical, INC. | $80.51 | 2025 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Inari Medical, INC. | $79.15 | 2021 | |
| Kerecis Limited | $70.29 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.26 | 2019-2020 | |
| Lemaitre Vascular, INC. | $41.59 | 2024-2025 | Artegraft Vascular Graft |
| Pfizer INC. | $38.71 | 2022-2023 | |
| Boston Scientific Corporation | $38.70 | 2023-2024 | Varithena Administration Pack |
| Reprise Biomedical, INC. | $36.69 | 2025 | Miro3d |
| Organogenesis INC. | $34.67 | 2023 | Puraply |
| Astrazeneca Pharmaceuticals LP | $33.15 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $32.33 | 2021 | |
| Cashflow Solutions, LLC | $26.18 | 2025 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Angiodynamics, INC. | $25.99 | 2024 | Venacure 1470 Pro |
| Integra Lifesciences Corporation | $22.09 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Medtronic, INC. | $20.52 | 2022 | |
| Amniox Medical, INC. | $20.45 | 2019 | |
| Artivion, INC. | $19.28 | 2019 | |
| Solventum Corporation | $18.42 | 2025 | V.A.C. Granufoam, Prevena, V.A.C.Ulta |
| Mimedx Group, INC. | $17.40 | 2025 | |
| Bioventus LLC | $14.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Panagiotis Iakovidis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.